< 0 1 0 1 O
5 1 2 1 2 B-upper_bound
ULN 3 6 3 6 I-upper_bound
if 7 9 7 9 O
there 10 15 10 15 O
is 16 18 16 18 O
liver 19 24 19 24 O
involvement 25 36 25 36 O
secondary 37 46 37 46 O
to 47 49 47 49 O
the 50 53 50 53 O
tumor 54 59 54 59 B-cancer

ANC>= 0 5 60 65 B-clinical_variable
1500 6 10 66 70 B-lower_bound
/ 10 11 70 71 I-lower_bound
mm^3 11 15 71 75 I-lower_bound

AST 0 3 76 79 B-clinical_variable
<3 4 6 80 82 O
the 7 10 83 86 I-upper_bound
upper 11 16 87 92 I-upper_bound
limit 17 22 93 98 I-upper_bound
of 23 25 99 101 I-upper_bound
normal 26 32 102 108 I-upper_bound
( 33 34 109 110 I-upper_bound
ULN 34 37 110 113 I-upper_bound
) 37 38 113 114 I-upper_bound

Active 0 6 115 121 B-chronic_disease
autoimmune 7 17 122 132 I-chronic_disease
disease 18 25 133 140 I-chronic_disease
requiring 26 35 141 150 O
disease 36 43 151 158 B-treatment
- 43 44 158 159 I-treatment
modifying 44 53 159 168 I-treatment
therapy 54 61 169 176 I-treatment

Adjuvant 0 8 177 185 B-treatment
IFN 9 12 186 189 I-treatment
- 12 13 189 190 I-treatment
a 13 14 190 191 I-treatment
, 14 15 191 192 O
is 16 18 193 195 O
allowed 19 26 196 203 O
if 27 29 204 206 O
last 30 34 207 211 O
dose 35 39 212 216 O
was 40 43 217 220 O
received 44 52 221 229 O
at 53 55 230 232 O
least 56 61 233 238 O
6 62 63 239 240 B-lower_bound
months 64 70 241 247 I-lower_bound
of 71 73 248 250 O
starting 74 82 251 259 O
study 83 88 260 265 O
treatment 89 98 266 275 B-treatment

Age 0 3 276 279 B-age
> 4 5 280 281 O
/= 5 7 281 283 O
18 8 10 284 286 B-lower_bound
years 11 16 287 292 I-lower_bound

Any 0 3 293 296 O
form 4 8 297 301 O
of 9 11 302 304 O
active 12 18 305 311 O
primary 19 26 312 319 O
or 27 29 320 322 O
secondary 30 39 323 332 O
immunodeficiency 40 56 333 349 B-chronic_disease

At 0 2 350 352 O
least 3 8 353 358 O
two 9 12 359 362 B-lower_bound
injectable 13 23 363 373 O
lesions 24 31 374 381 O
( 32 33 382 383 O
amenable 33 41 383 391 O
for 42 45 392 395 O
direct 46 52 396 402 O
injection 53 62 403 412 O
or 63 65 413 415 O
through 66 73 416 423 O
the 74 77 424 427 O
use 78 81 428 431 O
of 82 84 432 434 O
image 85 90 435 440 O
guidance 91 99 441 449 O
such 100 104 450 454 O
ultrasound 105 115 455 465 B-treatment
[ 116 117 466 467 I-treatment
US 117 119 467 469 I-treatment
] 119 120 469 470 I-treatment
, 120 121 470 471 O
CT 122 124 472 474 B-treatment
or 125 127 475 477 O
MRI 128 131 478 481 B-treatment
) 131 132 481 482 O
defined 133 140 483 490 O
as 141 143 491 493 O
any 144 147 494 497 O
injectable 148 158 498 508 O
cutaneous 159 168 509 518 B-chronic_disease
, 168 169 518 519 O
subcutaneous 170 182 520 532 B-treatment
, 182 183 532 533 O
nodal 184 189 534 539 B-chronic_disease
, 189 190 539 540 O
or 191 193 541 543 O
visceral 194 202 544 552 B-clinical_variable
melanoma 203 211 553 561 I-clinical_variable
lesion 212 218 562 568 I-clinical_variable
> 219 220 569 570 O
/= 220 222 570 572 O
10 223 225 573 575 B-lower_bound
mm 226 228 576 578 I-lower_bound
in 229 231 579 581 O
longest 232 239 582 589 O
diameter 240 248 590 598 O

Concurrent 0 10 599 609 O
systemic 11 19 610 618 O
steroid 20 27 619 626 B-treatment
therapy 28 35 627 634 I-treatment
higher 36 42 635 641 O
than 43 47 642 646 O
physiologic 48 59 647 658 O
dose 60 64 659 663 O
( 65 66 664 665 O
> 66 67 665 666 O
7.5 67 70 666 669 B-lower_bound
mg 71 73 670 672 I-lower_bound
/ 73 74 672 673 I-lower_bound
day 74 77 673 676 I-lower_bound
of 78 80 677 679 O
prednisone 81 91 680 690 B-treatment
or 92 94 691 693 O
equivalent 95 105 694 704 O
) 105 106 704 705 O

Hemoglobin 0 10 706 716 B-clinical_variable
> 11 12 717 718 O
9 12 13 718 719 B-lower_bound
g 14 15 720 721 I-lower_bound
/ 15 16 721 722 I-lower_bound
dL 16 18 722 724 I-lower_bound

Histologically 0 14 725 739 O
or 15 17 740 742 O
cytologically 18 31 743 756 O
confirmed 32 41 757 766 O
malignant 42 51 767 776 B-cancer
melanoma 52 60 777 785 I-cancer
from 61 65 786 790 I-cancer
skin 66 70 791 795 I-cancer
, 70 71 795 796 O
or 72 74 797 799 O
mucosal 75 82 800 807 B-cancer
melanoma 83 91 808 816 I-cancer
( 92 93 817 818 O
i.e. 93 97 818 822 O
ocular 98 104 823 829 B-cancer
melanoma 105 113 830 838 I-cancer
subjects 114 122 839 847 O
are 123 126 848 851 O
not 127 130 852 855 O
eligible 131 139 856 864 O
) 139 140 864 865 O

History 0 7 866 873 O
of 8 10 874 876 O
New 11 14 877 880 B-clinical_variable
York 15 19 881 885 I-clinical_variable
Heart 20 25 886 891 I-clinical_variable
Association 26 37 892 903 I-clinical_variable
class 38 43 904 909 I-clinical_variable
3 44 45 910 911 B-lower_bound
- 45 46 911 912 O
4 46 47 912 913 B-upper_bound
congestive 48 58 914 924 B-chronic_disease
heart 59 64 925 930 I-chronic_disease
failure 65 72 931 938 I-chronic_disease
or 73 75 939 941 O
history 76 83 942 949 O
myocardial 84 94 950 960 B-chronic_disease
infarction 95 105 961 971 I-chronic_disease
within 106 112 972 978 O
6 113 114 979 980 B-upper_bound
months 115 121 981 987 I-upper_bound
of 122 124 988 990 O
starting 125 133 991 999 O
study 134 139 1000 1005 O
treatment 140 149 1006 1015 O

History 0 7 1016 1023 O
of 8 10 1024 1026 O
clinically 11 21 1027 1037 O
manifested 22 32 1038 1048 O
CNS 33 36 1049 1052 B-cancer
metastases 37 47 1053 1063 I-cancer
, 47 48 1063 1064 O
except 49 55 1065 1071 O
if 56 58 1072 1074 O
brain 59 64 1075 1080 B-cancer
metastases 65 75 1081 1091 I-cancer
have 76 80 1092 1096 O
been 81 85 1097 1101 O
treated 86 93 1102 1109 O
, 93 94 1109 1110 O
are 95 98 1111 1114 O
stable 99 105 1115 1121 O
and 106 109 1122 1125 O
are 110 113 1126 1129 O
asymptomatic 114 126 1130 1142 O

Palliative 0 10 1143 1153 B-treatment
radiotherapy 11 23 1154 1166 I-treatment
to 24 26 1167 1169 O
a 27 28 1170 1171 O
limited 29 36 1172 1179 O
field 37 42 1180 1185 O
or 43 45 1186 1188 O
palliative 46 56 1189 1199 B-treatment
cryoablation 57 69 1200 1212 I-treatment
is 70 72 1213 1215 O
allowed 73 80 1216 1223 O
after 81 86 1224 1229 O
consultation 87 99 1230 1242 O
with 100 104 1243 1247 O
the 105 108 1248 1251 O
Principal 109 118 1252 1261 O
Investigator 119 131 1262 1274 O
, 131 132 1274 1275 O
at 133 135 1276 1278 O
any 136 139 1279 1282 O
time 140 144 1283 1287 O
during 145 151 1288 1294 O
the 152 155 1295 1298 O
study 156 161 1299 1304 O
participation 162 175 1305 1318 O
including 176 185 1319 1328 O
screening 186 195 1329 1338 O

Patients 0 8 1339 1347 O
who 9 12 1348 1351 O
have 13 17 1352 1356 O
previously 18 28 1357 1367 O
received 29 37 1368 1376 O
pembrolizumab 38 51 1377 1390 B-treatment
or 52 54 1391 1393 O
PD-/L1 55 61 1394 1400 B-treatment
blockade 62 70 1401 1409 I-treatment
therapy 71 78 1410 1417 I-treatment

Patients 0 8 1418 1426 O
with 9 13 1427 1431 O
a 14 15 1432 1433 O
negative 16 24 1434 1442 B-pregnancy
pregnancy 25 34 1443 1452 I-pregnancy
test 35 39 1453 1457 O
( 40 41 1458 1459 O
urine 41 46 1459 1464 O
or 47 49 1465 1467 O
serum 50 55 1468 1473 O
) 55 56 1473 1474 O

Patients 0 8 1475 1483 O
with 9 13 1484 1488 O
history 14 21 1489 1496 O
of 22 24 1497 1499 O
hematologic 25 36 1500 1511 B-cancer
malignancy 37 47 1512 1522 I-cancer

Pembrolizumab 0 13 1523 1536 B-treatment
such 14 18 1537 1541 O
as 19 21 1542 1544 O
: 21 22 1544 1545 O
condom 23 29 1546 1552 O
, 29 30 1552 1553 O
diaphragm 31 40 1554 1563 O
, 40 41 1563 1564 O
hormonal 42 50 1565 1573 O
, 50 51 1573 1574 O
IUD 52 55 1575 1578 O
, 55 56 1578 1579 O
or 57 59 1580 1582 O
sponge 60 66 1583 1589 O
plus 67 71 1590 1594 O
spermicide 72 82 1595 1605 O

Prior 0 5 1606 1611 O
malignancy 6 16 1612 1622 B-cancer

Seronegative 0 12 1623 1635 B-chronic_disease
for 13 16 1636 1639 O
HIV 17 20 1640 1643 B-chronic_disease
antibody 21 29 1644 1652 O

Serum 0 5 1653 1658 B-clinical_variable
creatinine 6 16 1659 1669 I-clinical_variable
< 17 18 1670 1671 O
/= 18 20 1671 1673 O
2.0 21 24 1674 1677 B-upper_bound
mg 25 27 1678 1680 I-upper_bound
/ 27 28 1680 1681 I-upper_bound
dl 28 30 1681 1683 I-upper_bound

Subjects 0 8 1684 1692 O
that 9 13 1693 1697 O
have 14 18 1698 1702 O
received 19 27 1703 1711 O
experimental 28 40 1712 1724 B-treatment
vaccines 41 49 1725 1733 I-treatment
or 50 52 1734 1736 O
other 53 58 1737 1742 O
immune 59 65 1743 1749 B-treatment
therapies 66 75 1750 1759 I-treatment
should 76 82 1760 1766 O
be 83 85 1767 1769 O
discussed 86 95 1770 1779 O
with 96 100 1780 1784 O
the 101 104 1785 1788 O
Principal 105 114 1789 1798 O
Investigator 115 127 1799 1811 O
to 128 130 1812 1814 O
confirm 131 138 1815 1822 O
eligibility 139 150 1823 1834 O

Total 0 5 1835 1840 O
bilirubin 6 15 1841 1850 B-clinical_variable
less 16 20 1851 1855 O
than 21 25 1856 1860 O
or 26 28 1861 1863 O
equal 29 34 1864 1869 O
to 35 37 1870 1872 O
2.0 38 41 1873 1876 B-upper_bound
mg 42 44 1877 1879 I-upper_bound
/ 44 45 1879 1880 I-upper_bound
dl 45 47 1880 1882 I-upper_bound

WBC 0 3 1883 1886 B-clinical_variable
> 4 5 1887 1888 O
3000 5 9 1888 1892 B-lower_bound
/ 9 10 1892 1893 I-lower_bound
mm^3 10 14 1893 1897 I-lower_bound

adequately 0 10 1898 1908 O
treated 11 18 1909 1916 O
basal 19 24 1917 1922 B-cancer
cell 25 29 1923 1927 I-cancer
or 30 32 1928 1930 I-cancer
squamous 33 41 1931 1939 I-cancer
cell 42 46 1940 1944 I-cancer
skin 47 51 1945 1949 I-cancer
cancer 52 58 1950 1956 I-cancer

except 0 6 1957 1963 O
in 7 9 1964 1966 O
patients 10 18 1967 1975 O
with 19 23 1976 1980 O
Gilbert 24 31 1981 1988 B-chronic_disease
's 31 33 1988 1990 I-chronic_disease
Syndrome 34 42 1991 1999 I-chronic_disease
who 43 46 2000 2003 O
must 47 51 2004 2008 O
have 52 56 2009 2013 O
a 57 58 2014 2015 O
total 59 64 2016 2021 O
bilirubin 65 74 2022 2031 B-clinical_variable
less 75 79 2032 2036 O
than 80 84 2037 2041 O
3.0 85 88 2042 2045 B-upper_bound
mg 89 91 2046 2048 I-upper_bound
/ 91 92 2048 2049 I-upper_bound
dl 92 94 2049 2051 I-upper_bound

in 0 2 2052 2054 B-cancer
- 2 3 2054 2055 I-cancer
situ 3 7 2055 2059 I-cancer
cervical 8 16 2060 2068 I-cancer
cancer 17 23 2069 2075 I-cancer

must 0 4 2076 2080 O
be 5 7 2081 2083 O
documented 8 18 2084 2094 O
within 19 25 2095 2101 O
14 26 28 2102 2104 B-upper_bound
days 29 33 2105 2109 I-upper_bound
of 34 36 2110 2112 O
screening 37 46 2113 2122 O
for 47 50 2123 2126 O
women 51 56 2127 2132 B-gender
of 57 59 2133 2135 O
childbearing 60 72 2136 2148 O
potential 73 82 2149 2158 O
( 83 84 2159 2160 O
WOCBP 84 89 2160 2165 O
) 89 90 2165 2166 O

women 0 5 2167 2172 B-gender
who 6 9 2173 2176 O
are 10 13 2177 2180 O
nursing 14 21 2181 2188 O

